These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 25920699)
1. Summary of major radiation fractionation and chemotherapy trials for organ preservation therapy in locally advanced head and neck squamous cell carcinoma. Parsons JT; Greene BD Pract Radiat Oncol; 2015; 5(5):343-349. PubMed ID: 25920699 [TBL] [Abstract][Full Text] [Related]
2. Evidence-based radiation oncology in head and neck squamous cell carcinoma. Corvò R Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300 [TBL] [Abstract][Full Text] [Related]
3. A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck. Budach W; Hehr T; Budach V; Belka C; Dietz K BMC Cancer; 2006 Jan; 6():28. PubMed ID: 16448551 [TBL] [Abstract][Full Text] [Related]
4. A multidisciplinary approach to squamous cell carcinomas of the head and neck: an update. Bernier J Curr Opin Oncol; 2008 May; 20(3):249-55. PubMed ID: 18391622 [TBL] [Abstract][Full Text] [Related]
5. Is induction chemotherapy the new standard in organ preservation treatment for locally advanced head and neck cancer in 2010? Porceddu SV Asia Pac J Clin Oncol; 2010 Jun; 6(2):75-6. PubMed ID: 20565417 [No Abstract] [Full Text] [Related]
6. Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer. Kies MS; Haraf DJ; Rosen F; Stenson K; List M; Brockstein B; Chung T; Mittal BB; Pelzer H; Portugal L; Rademaker A; Weichselbaum R; Vokes EE J Clin Oncol; 2001 Apr; 19(7):1961-9. PubMed ID: 11283128 [TBL] [Abstract][Full Text] [Related]
7. Altered fractionation and/or adjuvant chemotherapy in definitive irradiation of squamous cell carcinoma of the head and neck. Mendenhall WM; Riggs CE; Amdur RJ; Hinerman RW; Villaret DB Laryngoscope; 2003 Mar; 113(3):546-51. PubMed ID: 12616212 [TBL] [Abstract][Full Text] [Related]
8. The role of induction chemotherapy in the curative treatment of squamous cell cancer of the head and neck. Posner MR; Colevas AD; Tishler RB Semin Oncol; 2000 Aug; 27(4 Suppl 8):13-24. PubMed ID: 10952434 [TBL] [Abstract][Full Text] [Related]
9. Intensive induction chemotherapy and radiation for organ preservation in patients with advanced resectable head and neck carcinoma. Urba SG; Forastiere AA; Wolf GT; Esclamado RM; McLaughlin PW; Thornton AF J Clin Oncol; 1994 May; 12(5):946-53. PubMed ID: 8164046 [TBL] [Abstract][Full Text] [Related]
10. Organ preservation for advanced head and neck cancer concomitant chemoradiation. Brockstein B Cancer Treat Res; 2003; 114():235-48. PubMed ID: 12619544 [No Abstract] [Full Text] [Related]
11. Induction chemotherapy for head and neck cancer: recent data. Vokes EE Oncologist; 2010; 15 Suppl 3():3-7. PubMed ID: 21036882 [TBL] [Abstract][Full Text] [Related]
12. Phase I/II study of docetaxel, cisplatin, and concomitant boost radiation for locally advanced squamous cell cancer of the head and neck. Tsao AS; Garden AS; Kies MS; Morrison W; Feng L; Lee JJ; Khuri F; Zinner R; Myers J; Papadimitrakopoulou V; Lewin J; Clayman GL; Ang KK; Glisson BS J Clin Oncol; 2006 Sep; 24(25):4163-9. PubMed ID: 16943532 [TBL] [Abstract][Full Text] [Related]
13. Promising long-term results with attenuated adverse effects by methotrexate-containing sequential chemoradiation therapy in locally advanced head and neck squamous cell carcinoma. Tsai TL; Chu PY; Tai SK; Wang YF; Yang MH; Wang LW; Lirng JF; Chang SY Jpn J Clin Oncol; 2011 Oct; 41(10):1182-93. PubMed ID: 21862506 [TBL] [Abstract][Full Text] [Related]
14. RTOG 0522: a randomized phase III trial of concurrent accelerated radiation and cisplatin versus concurrent accelerated radiation, cisplatin, and cetuximab [followed by surgery for selected patients] for Stage III and IV head and neck carcinomas. Clin Adv Hematol Oncol; 2007 Feb; 5(2):79-81. PubMed ID: 17344795 [No Abstract] [Full Text] [Related]
15. The role of concurrent chemotherapy and radiation in the management of patients with squamous cell carcinomas of the head and neck. Suntharalingam M Semin Oncol; 2003 Aug; 30(4 Suppl 9):37-45. PubMed ID: 12908135 [TBL] [Abstract][Full Text] [Related]
16. Concurrent radiation chemotherapy for locally advanced head and neck carcinoma: are we addressing burning subjects? Ang KK J Clin Oncol; 2004 Dec; 22(23):4657-9. PubMed ID: 15534361 [No Abstract] [Full Text] [Related]
17. Bioreductive alkylating agent porfiromycin in combination with radiation therapy for the management of squamous cell carcinoma of the head and neck. Haffty BG; Son YH; Wilson LD; Papac R; Fischer D; Rockwell S; Sartorelli AC; Ross D; Sasaki CT; Fischer JJ Radiat Oncol Investig; 1997; 5(5):235-45. PubMed ID: 9372546 [TBL] [Abstract][Full Text] [Related]
18. Radiotherapy and chemotherapy in locally advanced head and neck squamous cell carcinoma. Krstevska V J BUON; 2009; 14(3):361-73. PubMed ID: 19810125 [TBL] [Abstract][Full Text] [Related]
19. The role of chemotherapy in locally advanced head and neck squamous cell carcinoma. Nwizu T; Ghi MG; Cohen EE; Paccagnella A Semin Radiat Oncol; 2012 Jul; 22(3):198-206. PubMed ID: 22687944 [TBL] [Abstract][Full Text] [Related]
20. Induction chemotherapy in the management of squamous cell carcinoma of the head and neck. Roman E; Raez LE; Santos ES Expert Rev Anticancer Ther; 2006 Sep; 6(9):1205-15. PubMed ID: 17020455 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]